Contrast-enhanced tissue Doppler imaging of the left atrial appendage is a new quantitative measure of spontaneous echocardiographic contrast in atrial fibrillation

European Journal of Echocardiography

Volumn 9, Issue 1, 2008, Pages 5-11

  Donal, Erwan ^a   Sallach, John A ^b   Murray, R Daniel ^c   Drinko, Jeanne K ^c   Jasper, Susan E ^c   Thomas, James D ^c   Klein, Allan L ^c  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF MICHIGAN   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Left atrium; Spontaneous echocardiographic contrast; Stroke; Tissue Doppler imaging

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CONTRAST ECHOCARDIOGRAPHY; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SHEAR RATE; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ALBUMINS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CONTRAST MEDIA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FLUOROCARBONS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; ROC CURVE;

EID: 43449118692     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1016/j.euje.2006.10.001     Document Type: Article

References (35)

1. Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R et al. Lessons from stroke prevention in atrial fibrillation trials. Ann Intern Med 2003;138:831-8.
2. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol 2003;91:9G-14G.
3. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
4. Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 2004;43:241-7.
5. Opolski G, Torbicki A, Kosior DA, Szulc M, Wozakowska-Kaplon B, Kolodziej P et al. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004;126:476-86.
6. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004;351:2373-83.
7. Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 1999;12:1080-7.
8. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 1993;22:1359-66.
9. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. J Am Coll Cardiol 1985;6:744-9.
10. Klein AL, Murray RD, Black IW, Chandra S, Grimm RA, DSa DA et al. Integrated backscatter for quantification of left atrial spontaneous echo contrast. J Am Coll Cardiol 1996;28:222-31.
11. Bashir M, Asher CR, Schaffer K, Murray RD, Apperson-Hansen C, Jasper SE et al. Left atrial appendage spontaneous echo contrast in patients with atrial arrhythmias using integrated backscatter and transesophageal echocardiography. Am J Cardiol 2001;88:923-7.
12. Flachskampf FA, Decoodt P, Fraser AG, Daniel WG, Roelandt JR; Subgroup on Transesophageal Echocardiography and Valvular Heart Disease; Working Group on Echocardiography of the European Society of Cardiology. Guidelines from the Working Group. Recommendations for performing transesophageal echocardiography. Eur J Echocardiogr 2001;2:8-21.
13. McGowan JH, Cleland JG. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 2003;146:388-97.
14. Stefanidis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur Heart J 2001;22:22-36.
15. Thomas L, Foster E, Hoffman JI, Schiller NB. The Mitral Regurgitation Index: an echocardiographic guide to severity. J Am Coll Cardiol 1999;33:2016-22.
16. Grimm RA, Stewart WJ, Arheart K, Thomas JD, Klein AL. Left atrial appendage 'stunning' after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol 1997;29:582-9.
17. Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice? JAMA 2003;290:2685-92.
18. Gorcsan J 3rd, Strum DP, Mandarino WA, Gulati VK, Pinsky MR. Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiography. Comparison with sonomicrometry and pressure-volume relations. Circulation 1997;95:2423-33.
19. Hatle L, Sutherland GR. Regional myocardial function-a new approach. Eur Heart J 2000;21:1337-57.
20. Bartel T, Müller S, Nesser HJ, Mohlenkamp S, Bruch C, Erbel R. Usefulness of motion patterns identified by tissue Doppler echocardiography for diagnosing various cardiac masses, particularly valvular vegetations. Am J Cardiol 1999;84:1428-33.
21. Donal E, Raud-Raynier P, Chagneau-Derrodes C, Fruge F, Coisne D. First case of myocardial metastasis of an epidermoid tumor. Value of Doppler tissue imaging. Arch Mal Coeur Vaiss 2001;94:231-5.
22. Limongelli G, Pacileo G, Cerrato F, Verrengia M, DiSimone A, Severino S et al. Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: noninvasive evidence of electrical and textural substrate for ventricular arrhythmias. J Am Soc Echocardiogr 2003;16:803-7.
23. Vitale DF, Bonow RO, Calabro R, DeCristofaro M, Pacileo G, Caso P et al. Myocardial ultrasonic tissue characterization in pediatric and adult patients with hypertrophic cardiomyopathy. Circulation 1996;94:2826-30.
24. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004;110:3081-7.
25. Donal E, Coisne D, D'hooge J, Christiaens L, Allal J. Tissue characterization by study of myocardial response to ultrasound. Review of the literature and perspectives. Arch Mal Coeur Vaiss 2000;93:301-8.
26. Ohyama H, Hosomi N, Takahashi T, Mizushige K, Osaka K, Kohno M et al. Comparison of magnetic resonance imaging and transesophageal echocardiography in detection of thrombus in the left atrial appendage. Stroke 2003;34:2436-9.
27. Kamp O, Verhorst PM, Welling RC, Visser CA. Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J 1999;20:979-85.
28. Asinger RW, Koehler J, Pearce LA, Zabalgoitia M, Blackshear JL, Fenster PE et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 1999;12:1088-96.
29. Daniel WG, Nellessen U, Schroder E, Nonnast-Daniel B, Bednarski P, Nikutta P et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988;11:1204-11.
30. Ito T, Suwa M, Nakamura T, Miyazaki S, Hirota Y, Kawamura K. Influence of warfarin therapy on left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. Am J Cardiol 1999;84:857-9.
31. Jaber WA, Prior DL, Thamilarasan M, Grimm RA, Thomas JD, Klein AL et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. Am Heart J 2000;140:150-6.
32. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
33. Gonzalez-Torrecilla E, Garcia-Fernandez MA, Perez-David E, Bermejo J, Moreno M, Delcan JL. Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation. Am J Cardiol 2000;86:529-34.
34. Black IW. Left atrial spontaneous echo contrast and embolism. Stroke 1994;25:1295-6.
35. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE et al. ACUTE investigators Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 2005;96:935-41.